source
- Lilly data show lower-dose GLP-1 injections and oral pill help sustain weight lossEli Lilly presented new research on how patients who have lost weight with GLP‑1 medicines can maintain that loss over time. The studies followed people who had achieved significant reductions usin…
- Assertio rejects Garda bid, accepts Zydus offer valuing company at $23.50 per shareAssertio Holdings announced it has terminated its pending acquisition by Garda Therapeutics after the board approved a higher offer from another suitor. The new proposal from Zydus Worldwide value…